The effect of active diuretic therapy on the sodium balance in patients with acute decompensation of chronic heart failure
- Authors: Davydov V.V.1, Arehina E.L.2
-
Affiliations:
- Altai State Medical University
- Сity Clinical Hospital №8
- Issue: Vol 24, No 1 (2022)
- Pages: 60-65
- Section: Article
- URL: https://journals.rcsi.science/2075-1753/article/view/106365
- DOI: https://doi.org/10.26442/20751753.2022.1.201379
- ID: 106365
Cite item
Full Text
Abstract
Background. Active dehydration of patients with acute decompensation of chronic heart failure (АDCHF) was often accompanied by the development of hyponatremia. This increased the time of hospitalization and worsened the prognosis. The complication was associated with the side effects of furosemide.
Aim. To compare the effect of dehydration and the state of sodium balance after using different methods of parenteral administration of furosemide at an early stage of treatment of АDCHF.
Materials and methods. Patients with АDCHF (n=125) were divided into two groups. Group 1 received furosemide as bolus injections, group 2 as an extended intravenous infusion. The process of dehydration was controlled by the amount of urine and body weight loss per day. The effect was considered satisfactory if the body weight decreased by 1.0–2.0 kg per day. The plasma sodium level was studied on 1, 5, 10 days.
Results. In group 2, the satisfactory effect of dehydration was observed 1.7 times more often than in group 1 (p<0.05). In group 2 patients on the 5th day of therapy, the number of cases of hyponatremia was 2.3 times less (p<0.05). Hyponatremia developed little in patients with a satisfactory effect of dehydration. On the 10th day, the number of cases of hyponatremia in the groups did not significantly differ.
Conclusion. Prolonged intravenous infusion of furosemide allowed more control of the dehydration process and the plasma sodium level at an early stage of therapy in patients with АDCHF.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Vladimir V. Davydov
Altai State Medical University
Author for correspondence.
Email: 6davv@mail.ru
ORCID iD: 0000-0001-7667-910X
D. Sci. (Med.), Prof., Altai State Medical University
Russian Federation, BarnaulEkaterina L. Arehina
Сity Clinical Hospital №8
Email: arehina_katerina@mail.ru
ORCID iD: 0000-0002-7049-5585
Deputy Chief doctor, Сity Clinical Hospital №8
Russian Federation, BarnaulReferences
- Арутюнов А.Г., Драгунов Д.О., Арутюнов Г.П., и др. Влияние величины дозы основных препаратов на риск повторной госпитализации пациентов с хронической сердечной недостаточностью. Терапевтический архив. 2016;88(1):29-34 [Arutyunov AG, Dragunov DO, Arutyunov GP, et al. Impact of the dosing of basic drugs on the risk of rehospitalization in patients with chronic heart failure. Terapevticheskii arkhiv (Ter. Arkh.). 2016;88(1):29-34 (in Russian)]. doi: 10.17116/terarkh201688129-34
- Ларина В.Н. Выбор эффективного диуретика для терапии хронической сердечной недостаточности на амбулаторном этапе: доводы в пользу торасемида. Consilium Medicum. 2018;20(10):29-35 [Larina VN. Choice of effective diuretic for congestive heart failure treatment at the outpatient stage: arguments for torasemide use. Consilium Medicum. 2018;20(10):29-35 (in Russian)]. doi: 10.26442/2075-1753_2018.10.29-35
- Бойцов С.А., Готье С.В., Жиров И.В., и др. Рекомендации по ведению пациентов с острой сердечной недостаточностью на догоспитальном и госпитальном этапах оказания медицинской помощи (часть 2). Неотложная кардиология. 2017;1:34-59 [Boitsov SA, Gauthier SV, Zhirov IV, et al. A clinical guideline for management of patients with acute heart failure at pre-hospital and hospital stages of care delivery (part 2). Emergency Cardiology. 2017;1:34-59 (in Russian)].
- Costanzo MR. The Cardiorenal Syndrome in Heart Failure. Heart Fail Clin. 2020;16(1):81-97. doi: 10.1016/j.hfc.2019.08.010
- Hsu S, Bansal N. Updates in the management of heart failure for the chronic kidney disease patient. Curr Opin Nephrol Hypertens. 2019;28(3):262-6. doi: 10.1097/MNH.0000000000000497
- Chitturi C, Novak JE. Diuretics in the Management of Cardiorenal Syndrome. Adv Chronic Kidney Dis. 2018;25(5):425-33. doi: 10.1053/j.ackd.2018.08.008
- Курлыкина Н.В., Середенина Е.М., Орлова Я.А. Современные аспекты применения петлевых диуретиков при сердечной недостаточности. Терапевтический архив. 2017;89(9):115-9 [Kurlykina NV, Seredenina EM, Orlova YаA. Use of loop diuretics in heart failure: current aspects. Terapevticheskii arkhiv (Ter. Arkh.). 2017;89(9):115-9 (in Russian)]. doi: 10.17116/terarkh2017899115-119
- Sturdik I, Adamcova M, Kollerova J, et al. Hyponatraemia is an independent predictor of in-hospital mortality. Eur J Intern Med. 2014;25(4):379-82. doi: 10.1016/j.ejim.2014.02.002
- Ватутин Н.Т., Шевелёк А.Н., Загоруйко А.Н. Клиническая и прогностическая значимость гипонатриемии у больных с декомпенсацией хронической сердечной недостаточности. Архивъ внутренней медицины. 2018;8(5):372-81 [Vatutin NT, Shevelyok AN, Zagoruiko AN. Clinical and prognostic value of hyponatremia in patients with chronic heart failure. The Russian Archives of Internal Medicine. 2018;8(5):372-81 (in Russian)]. doi: 10.20514/2226-6704-2018-8-5-372-381
- Holland-Bill L, Christiansen CF, Heide-Jørgensen U, et al. Hyponatremia and mortality risk: a Danish cohort study of 279 508 acutely hospitalized patients. Eur J Endocrinol. 2015;173(1):71-81. doi: 10.1530/EJE-15-0111
- Palazzuoli A, Ruocco G. Heart-Kidney Interactions in Cardiorenal Syndrome Type 1. Adv Chronic Kidney Dis. 2018;25(5):408-17. doi: 10.1053/j.ackd.2018.08.013
- Пониковский П., Вурс А.А., Анкер С.Д., и др. Рекомендации ESC по диагностике и лечению острой и хронической сердечной недостаточности 2016. Российский кардиологический журнал. 2017;1(141):7-81 [Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Russian Journal of Cardiology. 2017;1(141):7-81 (in Russian)]. doi: 10.15829/1560-4071-2017-1-7-81
- Мареев В.Ю., Фомин И.В., Агеев Ф.Т., и др. Клинические рекомендации. Хроническая сердечная недостаточность (ХСН). Сердечная недостаточность. 2017;18(1):3-40 [Mareev VYu, Fomin IV, Ageev FT, et al. Chronic heart failure (CHF). Russian Heart Failure Journal. 2017;18(1):3-40 (in Russian)]. doi: 10.18087/RHFJ.2017.1.2346
- Mariano F, Mella A, Vincenti M, Biancone L. Furosemide as a functional marker of acute kidney injury in ICU patients: a new role for an old drug. J Nephrol. 2019;32(6):883-93. doi: 10.1007/s40620-019-00614-1
- Jalaba S, Palermo J, Budavari AI. Which dosing of furosemide is better in acute decompensated heart failure? JAAPA. 2017;30(3):11-2. doi: 10.1097/01.JAA.0000512242.43624.7a
- Spasovski G, Vanholder R, Allolio B, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Intensive Care Med. 2014;40(3):320-31. doi: 10.1007/s00134-014-3210-2